From: Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer
Odds ratio
95%CI
P
Lower
Upper
Rad score
1.270105
3.832
3.418108
< 0.001
Age
0.910
0.184
0.989
0.045
Stage n1
0.075
5.88010–5
4.0456
0.260
Stage n2
6.030
0.421
86.171
0.171
Stage n3
1.990
0.139
23.380
0.584
Stage M
0.153
0.022
0.777
0.035